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Abstract
Infection with the trematode parasite Schistosoma mansoni results in distinct heterogeneity of disease severity both in
humans and in mice. In the experimental mouse model, severe disease is characterized by pronounced hepatic egg-induced
granulomatous inflammation mediated by CD4 Th17 cells, whereas mild disease is associated with reduced hepatic
inflammation in a Th2-skewed cytokine environment. Even though the host’s genetic background significantly impacts the
clinical outcome of schistosomiasis, specific gene(s) that contribute to disease severity remain elusive. We investigated the
schistosome infection in wild-derived mice, which possess a more diverse gene pool than classically inbred mouse strains
and thus makes them more likely to reveal novel mechanisms of immune regulation. We now show that inbred wild-derived
MOLF mice develop severe hepatic inflammation with high levels of IL-17. Congenic mice with a MOLF locus in
chromosome 6, designated Why1, revealed high pathology and enabled the identification of Irak2 as the pathogenic gene.
Although IRAK-2 is classically associated with TLR signaling, adoptive transfer of CD4 T cells revealed that IRAK-2 mediates
pathology in a CD4 T cell specific manner by promoting Th17 cell development through enhancement of IL-1b-induced
activation of transcription factors RORct and BATF. The use of wild-derived mice unravels IRAK-2 as a novel regulator of IL-1-
induced pathogenic Th17 cells in schistosomiasis, which likely has wide-ranging implications for other chronic inflammatory
and autoimmune diseases.
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Introduction
The genetic analysis of complex traits has been critical to our
understanding of the molecular mechanisms that underlie disease
processes. Quantitative trait loci (QTL) are genomic intervals,
whose variation is responsible for the majority of genetic diversity
in human disease susceptibility and severity. As a model of human
genetics, classical inbred mouse strains have been instrumental in
identifying QTL. Murine schistosomiasis represents an extensively
characterized model of a major human infectious disease that
shares similar mechanistic features with many autoimmune and
chronic inflammatory diseases [1,2]. Although several QTL
underlying pathology in schistosomiasis have been identified to
date, mouse genetic studies have not entirely recapitulated the
genetic complexity that is likely to determine the disease course in
humans. One reason for this is the relatively limited genetic
diversity among classically inbred strains. These mice are derived
from a restricted number of founder animals predominantly within
the Mus mus domesticus subspecies and therefore do not reach the
level of diversity observed in humans [3,4]. We reasoned that this
limited diversity was a major problem that has made it difficult to
identify genes that underlie even well defined traits, leaving a
compelling need for new models of genetic analysis.
Wild-derived inbred mice diverged from a common ancestor
with classical strains more than one million years ago. As a result
of this early divergence, many of the wild-derived strains have
large genomic regions originating from the subspecies M. m.
musculus and M. m. castaneus[3,4], which provides them with a
unique and more genetically diverse gene pool compared with
classically inbred strains. The genetic diversity of wild-derived
mice resembles that seen in humans, which makes them more
suitable for the analysis of complex traits, such as host-pathogen
interactions. Furthermore, novel phenotypes identified in wild-
derived mice are likely to have increased biological relevance given
that they have arisen in an evolutionarily driven context[5]. Wild-
derived mice have proved useful as genetic models in identifying
novel phenotypic variants in studies exploring host responses to
infection with pathogens, such as Salmonella typhimurium[6], as well
as identifying several loci that confer resistance to TNFa induced
toxic shock[7].
The main pathology in murine schistosomiasis consists of a
granulomatous inflammatory and fibrosing reaction in the liver and
intestine against tissue trapped parasite eggs, which is a host
adaptive immune response mediated by CD4 T cells specific for
schistosome egg antigens (SEA)[1,8,9]. Following infection with S.
mansoni, most humans develop mild, ‘‘intestinal schistosomiasis’’,
however 5-10% develop a severe inflammatory and fibrosing
response, which leads to a potentially lethal form of the disease,
‘‘hepatosplenic schistosomiasis’’[10]. This variation also exists in a
mouse model of schistosomiasis, where CBA mice develop
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(BL/6) mice develop significantly smaller granulomas with milder
hepatic inflammation[11,12].
Th17 cells represent a unique lineage of T cells that act as
potent proinflammatory mediators and have been shown to play a
significant role in a number of inflammatory and autoimmune
diseases, such as experimental autoimmune encephalomyelitis
(EAE), collagen-induced arthritis, psoriasis and inflammatory
bowel disease[13,14,15,16]. Th17 cells are characterized by their
expression of the transcription factor RORct[17] as well as by
their requirement of IL-6, TGF-b, IL-23 and IL-21 to differentiate
and expand[18,19,20,21,22,23]. IL-1b is also of particular
importance in Th17 cell differentiation and pathogenesis
[24,25,26,27]. In schistosomiasis, IL-23 and IL-1b are necessary
for IL-17 production in response to parasite eggs and severe
immunopathology correlates with increased production of IL-
17[28,29,30]. Furthermore, in vivo neutralization of IL-17
significantly reduces the immunopathology[12].
In an attempt to identify novel mechanisms that govern severe
disease, we assessed the schistosome infection in wild-derived
inbred mice of the MOLF strain. We previously have shown that
in MOLF mice, TLR ligation in macrophages in vitro leads to
significantly higher transcription of proinflammatory cytokines
than in classically inbred BL/6 mice [31]. To examine if their bias
towards a proinflammatory response also occurs in an in vivo
infection model, we infected MOLF mice with S. mansoni and
found that they develop severe liver immunopathology associated
with a high Th17 response. Although we anticipated identifying
novel factors that regulate T cell function via APC responses, we
were surprised to find a T cell-intrinsic regulator of IL-17
production. We now demonstrate that a single gene, Irak2,i s
capable of controlling severe pathology in murine schistosomiasis.
Furthermore, we provide evidence of a novel role for IRAK-2 in
IL-1b-mediated pathogenic Th17 cell development. Our study
also demonstrates the utility of wild-derived mice as a model to
identify novel gene networks and further refine our understanding
of immune signaling pathways.
Results
MOLF mice develop severe immunopathology with high
levels of IL-17 following schistosome infection
Seven weeks after infection with 85 cercariae of S. mansoni,
MOLF mice were debilitated, as defined by hunched posture,
reduced activity and scruffy appearance, and exhibited signifi-
cantly enhanced hepatic egg-induced immunopathology when
compared with BL/6 mice, with granulomatous lesions in some
instances larger than those seen in the high-pathology control
CBA mice (Fig. 1A). Individual granulomas from MOLF mice
consisted of significantly larger perioval aggregates of macrophag-
es/histiocytes and lymphocytes admixed with eosinophils and
neutrophils, with a greater tendency to infiltrate the surrounding
hepatic parenchyma than in BL/6 mice (Fig. 1B). However, the
number of schistosome eggs present in the livers did not
significantly differ between the mouse groups, indicating that the
parasite load did not correlate with the extent of pathology
(Fig. 1C). Analysis of antigen specific cytokine production by
schistosome egg antigen (SEA)-stimulated draining mesenteric
lymph node (MLN) cells (MLNC) from infected mice revealed that
MOLF mice produced strikingly higher amounts of IL-17 than
BL/6 and even CBA mice (Fig. 1D). There also was a significant,
but less pronounced, increase in IFN-c, IL-6 and TNFa (Fig. 1E–
G). However, there were no significant differences in IL-4, IL-5 or
IL-10 between BL/6, CBA and MOLF mice (Fig. 1H–J).
Cytokine production in MLNC typically correlates with that
produced in the affected liver. In order to confirm this in MOLF
mice, we isolated granuloma cells (GC) and analyzed their specific
response to SEA. Similar to the MLNC, MOLF GC produced
very high amounts of IL-17 compared with both BL/6 and CBA
mice (Fig. 1K). There also was higher IFN-c, IL-6 and TNFa
production in MOLF vs. BL/6 mice, but only in the case of TNFa
was the difference statistically significant (Fig. 1L–N). There were
no significant differences in IL-4, IL-5 or IL-10 (data not shown).
Analysis of cytokines involved in the development of Th17 cells
revealed that IL-1b, as well as IL-23p19 and IL-12p40, the
subunits that make up IL-23, were expressed at much higher levels
in the livers of MOLF mice than BL/6 and CBA mice (Fig. 1O–
Q), whereas the difference in the IL-12-specific subunit IL-12p35
was less striking (Fig. 1R). These results demonstrate that wild-
derived MOLF mice produce exceedingly high levels of Th17-
related cytokines, suggesting a potentially novel mechanism of
severe immunopathology.
Severe immunopathology and increased IL-17
production are controlled by the MOLF allele of the Why1
locus
We previously mapped the IL-6 hyper-responsiveness of MOLF
macrophages to TLR stimulation to a dominant locus on
chromosome 6, designated Why1[32]. Since MOLF mice reacted
to schistosome infection with an overwhelmingly proinflammatory
response, we postulated that the Why1 locus may also play a role in
this phenotype in the context of live infection. To assess the effect
of the Why1 locus directly, we used congenic mice (Why1 mice),
which contain the MOLF allele of the Why1 locus on a BL/6
background. After a 7-week schistosome infection, Why1 mice
appeared debilitated, as defined above, and displayed a significant
increase in hepatic granulomatous inflammation compared with
BL/6 mice, although not to the same extent as MOLF mice
(Fig. 2A), with the differences not attributable to dissimilar egg
burdens (Fig. 2B). There was significantly greater IL-17, IFN-c,
IL-6 and TNFa production by SEA-stimulated MLNC in Why1
vs. BL/6 mice (Fig. 2C–F), although IL-4, IL-5 or IL-10 were not
Author Summary
Schistosomes are trematode helminths that cause wide-
spread disease in vertebrates and are responsible for over
200 million human infections worldwide. The species
Schistosoma mansoni causes a hepatic granulomatous
inflammatory and fibrosing reaction against tissue trapped
parasite eggs that varies greatly in humans and among
mouse strains, implying that the host’s genetic back-
ground plays a critical role in determining disease severity.
Although exacerbated hepatic inflammation is known to
be associated with an increase in CD4 Th17 cells, specific
genes conducive to high pathology are unknown. In this
study we used genetically diverse inbred wild-derived
mice and found that their natural severe immunopathol-
ogy and high IL-17 levels are regulated by the interleukin-1
(IL-1) receptor-associated kinase-like 2 (IRAK-2). We dem-
onstrate that T cell intrinsic IRAK-2 affects disease severity
by enhancing the development of Th17 cells, which results
from an increased sensitivity to IL-1b induced activation of
the lineage-specific transcription factors RORct and BATF.
Our findings thus identify IRAK-2 as a single regulator of
pathogenic Th17 cell development in murine schistosomi-
asis and reveal a novel mechanism that is likely to operate
in other chronic inflammatory and autoimmune diseases.
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PLoS Pathogens | www.plospathogens.org 2 October 2011 | Volume 7 | Issue 10 | e1002272Figure 1. Schistosome-infected wild-derived MOLF mice develop severe egg-induced immunopathology and a proinflammatory
cytokine profile. After a 7-week infection, BL/6, CBA and MOLF mice were analyzed for hepatic immunopathology and cytokine expression. (A)
Granuloma size was measured by morphometric analysis. At least 15 granulomas were measured per liver in 5 individual mice per group. Error bars
represent the mean +/- SD of granuloma size within a group. B) H & E stain of representative hepatic egg granulomas from BL/6 (left panel) and MOLF
mice (right panel). (C) Mean +/- SD of number of S. mansoni eggs in 1 mm
2 fields on H/E stained liver sections. 10–20 fields were counted per liver
section and 10–15 livers were counted per mouse group. MLNC production of IL-17, IFN- c, IL-6 and TNFa (D-G) and IL-4, IL-5 and IL-10 (H-J), and GC
production of IL-17, IFN-c, IL-6 and TNFa (K-N) following stimulation with 15 mg/ml of SEA for 48 hours, as measured by ELISA. Expression of IL-1b, IL-
23p19, IL-12p40 and IL-12p35 (O-R) was measured by real-time quantitative RT-PCR. RNA was isolated from the livers of infected mice and data were
normalized to GAPDH. Error bars represent means of triplicate determinations +/- SD. Results are representative of at least 4 independent
experiments with at least 5 mice per group. P values were determined by one-way ANOVA. ns = not significant.
doi:10.1371/journal.ppat.1002272.g001
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23p19 (Fig. 2J,K), but not of IL-12p40 or IL-12p35 (Fig. 2L,M),
was also higher in Why1 vs. BL/6 mice. These findings
demonstrate that Why1 mice largely recapitulate the pathology
and IL-17 secretion seen in MOLF mice, and identify Why1 as a
key locus associated with increased egg-induced immunopathology
and Th17 cell development.
Severe immunopathology and increased IL-17
production controlled by the Why1 locus are mediated
by CD4 T cells
The Why1 locus contains .200 possible causal genes that could
underlie pathology in a complex trait such as the response to
schistosome infection. We therefore sought to reduce the number
of possible candidate genes by further defining the phenotype of
Why1 mice. Based on previous mapping of the Why1 locus in
macrophages[31,32], we hypothesized that severe disease and
increased IL-17 production were induced by innate immune cells.
To this effect, in order to avoid bias towards any one particular
APC type, we used an in vitro system involving bulk naı ¨ve splenic
APC together with CD4 T cells isolated from MLN of infected
mice. SEA-stimulated Why1 APC-CD4 T cell cocultures pro-
duced markedly higher levels of IL-17 than BL/6 controls
(Fig. 3A). However, surprisingly, Why1 T cells in combination
with BL/6 APC resulted in higher IL-17 production than Why1
APC in combination with BL/6 T cells, which did not significantly
differ from the IL-17 produced by the all-BL/6 coculture;
moreover, Why1 T cells in combination with either Why1 or
BL/6 APC resulted in high IL-17 production (Fig. 3A). These
findings suggest that CD4 T cells play a decisive role in dictating
Figure 2. Severe egg-induced immunopathology and proinflammatory cytokine production are controlled by the Why1 locus. After
a 7-week infection, BL/6, MOLF and Why1 mice were analyzed for hepatic immunopathology and cytokine expression. (A) Granuloma size was
measured by morphometric analysis. At least 15 granulomas were measured per liver in 5 individual mice per group. Error bars represent the mean
+/- SD of granuloma size within a group. (B) Mean +/- SD of number of S. mansoni eggs in 1 mm
2 fields on H/E stained liver sections. 10–20 fields
were counted per liver section and 10–15 livers were counted per mouse group. MLNC production of IL-17, IFN- c, IL-6 and TNFa (C-F) and IL-4, IL-5
and IL-10 (G-I) following stimulation with 15 mg/ml of SEA for 48 hours, as measured by ELISA. Expression of IL-1b, IL-23p19, IL-12p40 and IL-12p35
(J-M) was measured by real-time quantitative RT-PCR. RNA was isolated from the livers of infected mice and data were normalized to GAPDH. Error
bars represent means of triplicate determinations +/- SD. Results are representative of at least 3 independent experiments with at least 5 mice per
group. P values were determined by one-way ANOVA. ns = not significant.
doi:10.1371/journal.ppat.1002272.g002
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from infected Why1 mice, an influence of Why1 APC on
impending Th17 cell development could not be excluded. We
therefore adoptively transferred naı ¨ve splenic CD4 T cells from
uninfected Why1 mice to allow antigen specific Th17 cell
differentiation to take place in vivo in the absence of Why1 APC.
Figure 3. Why1-dependent severe egg-induced immunopathology is mediated by CD4 T cells. (A) The indicated combinations of CD4 T
cells from 7 week-infected mice plus normal irradiated splenic APC were stimulated with SEA for 48 hours, and IL-17 production was measured by
ELISA. (B-F) Purified naı ¨ve splenic BL/6 or Why1 CD4 T cells (8610
6) were injected i.v. into sublethally irradiated BL/6 recipient mice, which were
subsequently infected with S. mansoni. Infected BL/6 and Why1 mice are shown for comparison. (B) Granuloma size in recipient mice was measured
by morphometric analysis. IL-17 (C-D) and IFN-c (E-F) production by bulk MLNC (C,E) and purified MLN CD4 T cells plus irradiated splenic APC (D,F)
stimulated with SEA for 48 hours, was measured by ELISA. Error bars represent means of triplicate determinations +/- SD. Results are representative of
two (A) or three (B-F) independent experiments with at least 4 mice per group. P values were determined by one-way ANOVA. ns = not significant.
doi:10.1371/journal.ppat.1002272.g003
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increase in granulomatous inflammation in infected BL/6
recipients, whereas a similar transfer of BL/6 T cells had no
effect. Furthermore, SEA stimulated bulk MLNC (Fig. 3C), or
MLN CD4 T cells (Fig. 3D), from infected BL/6 mice recipients
of Why1 T cells produced significantly more IL-17 than those
receiving BL/6 T cells. There was also an increase in IFN-c,
although to a lesser extent than IL-17 (Fig. 3E,F). These results
indicate that the Why1 locus controls severe immunopathology
and enhances Th17 cell development via a CD4 T cell-mediated
mechanism.
IRAK-2 regulates IL-17 production by CD4 T cells
Why1 CD4 T cells confer enhanced immunopathology and IL-
17 production to infected recipient BL/6 mice, however, the
cytokine responses of Why1 T cells in the absence of schistosome
infection are unknown. To determine if an inherent proinflam-
matory bias exists, Why1 and BL/6 CD4 T cells were isolated by
negative selection from the spleens of naı ¨ve uninfected mice and
stimulated with anti-CD3/CD28. Both displayed similar basal
levels of cytokine mRNA, however, there were significantly higher
levels of IL-17 and IFN-c in stimulated Why1 T cells than in BL/6
T cells (Fig. 4A,B), while levels of IL-4 were higher in BL/6 T
Figure 4. IRAK-2 is necessary for CD4 T cell-specific IL-17 production. (A-C) IL-17, IFN-c and IL-4 mRNA expression by naı ¨ve CD4 T cells from
BL/6 and Why1 mice, either unstimulated (0 h), or stimulated with anti-CD3/CD28 for 48 hours, as measured by quantitative real-time PCR. (D-F) BL/6
and Why1 CD4 T cells were first treated with shRNA against IRAK-2 or control GFP and then stimulated with anti-CD3/CD28 for 48 hours. IL-17, IFN-c
and IL-4 mRNA expression was measured by quantitative real-time PCR. (G) To assess knockdown efficiency, mRNA was harvested and cDNA was
amplified with IRAK-2 or GAPDH specific primers, and expression was measured by quantitative real-time PCR. (H) IL-17 production by naive CD4 T
cells from BL/6 and Why1 mice, either unstimulated (0 h), or stimulated with anti-CD3/CD28 for 48 hours, as measured by ELISA. (I-J). IL-17
production in BL/6 and Why1 CD4 T cells pretreated with shRNA against IRAK-2 or control GFP and then stimulated with anti-CD3/CD28 for 48 and
96 hours, as measured by ELISA. Error bars represent means of triplicate determinations +/- SD from one of three independent experiments with
similar results. P values were determined by one-way ANOVA and Students t test. ns = not significant.
doi:10.1371/journal.ppat.1002272.g004
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cells are biased towards a Th17/Th1 proinflammatory phenotype.
Using shRNA knockdown technology, we previously demon-
strated that Irak2 is the gene responsible for the enhanced
proinflammatory response of Why1-derived macrophages follow-
ing TLR stimulation [31]. This observation supported the notion
that Irak2 is primarily involved in innate immune response
signaling. To investigate whether there is a direct involvement of
IRAK2 in up-regulation of inflammatory cytokines in activated
Why1 T cells, we employed shRNA technology to examine the
effect of IRAK-2 knockdown on levels of cytokine mRNA. We
observed a significant reduction in IL-17 mRNA induced by
IRAK-2-specific (but not by control shGFP) hairpin treatment in
Why1 T cells (Fig. 4D). Knockdown of IRAK-2 also suppressed
IL-17 by BL/6 T cells (Fig. 4D), indicating that its effect is not
specific to MOLF mice. Infection with the IRAK-2-specific
hairpin led to a specific decrease in IL-17 expression, which
strongly suggests that IRAK-2 is involved in transcriptional up-
regulation of IL-17. Interestingly, there was no significant effect on
IFN-c (Fig. 4E) or IL-4 (Fig. 4F). Knockdown of IRAK-2 in BL/
6 and Why1 T cells was confirmed by mRNA analysis due to the
lack of a suitable antibody against IRAK-2 (Fig. 4G).
To confirm these results, we measured the effect of IRAK-2 on
IL-17 protein levels. Why1 T cells stimulated with anti-CD3/
CD28 produced significantly more IL-17 than their BL/6
counterparts (Fig. 4H). Furthermore, knockdown of IRAK-2
significantly decreased IL-17 production in both Why1 and BL/6
T cells at 48 and 96 hours following stimulation, indicating that
this effect was stable over time (Fig. 4I, J). Unstimulated cells
produced no detectable cytokine at either time point, and
knockdown of IRAK-2 did not significantly affect IFN-c or IL-4
protein levels (data not shown). IFN-c, unlike IL-17, is largely
dependent on the JAK1/STAT1 activation pathway, whereas IL-
17’s promoter has well characterized consensus sites for the NFAT
and NF-kB transcription factors [33,34,35]. We thus postulate that
the specific effect of IRAK-2 on IL-17 is related to its role in
activating NF-kB and p38 MAP kinase. These results uncover a
novel role for IRAK-2 in directing Th17 cell polarization.
Figure 5. IRAK-2 mediates severe egg-induced immunopathology and CD4 T cell IL-17 production. IRAK-2-/-, littermate IRAK-2-/+ and
BL/6 mice were, or were not, immunized s.q. with 50 mg of SEA/CFA prior and following infection, as previously described. (A) Granuloma size was
measured by morphometric analysis after 7 weeks of infection. At least 30 granulomas were measured per liver in 5-7 individual mice per group. Error
bars represent the mean +/- SD of granuloma size within a group. (B) IL-17, (C) IFN-c,( D) IL-4 and (E) IL-5 production by CD4 MLN T cells plus
irradiated splenic APC, stimulated with SEA for 48 hours, was measured by ELISA. Error bars represent means of triplicate determinations +/- SD.
Results are representative of 2 independent experiments. P values were determined by one-way ANOVA. ns = not significant.
doi:10.1371/journal.ppat.1002272.g005
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infection in vivo
To directly assess the effect of IRAK-2 on the schistosome
infection in vivo, we examined the immunopathology and cytokine
profile in IRAK-2-deficient (IRAK-2-/-) mice. Since naturally
high-pathology IRAK-2-/- mice are currently not available, we
took advantage of a model in which severe egg-induced
immunopathology with high IL-17 levels can be induced in
infected BL/6 mice by immunization with SEA in CFA (SEA/
CFA) [12]. This model shares many attributes with naturally
occurring high pathology, and has been instrumental in identifying
mechanisms controlling the elevated Th17 respons-
es[12,30,36,37]. After 7 weeks of infection, the SEA/CFA-
immunized IRAK-2-/- mice appeared healthier and exhibited
significantly reduced granulomatous inflammation when com-
pared to similarly treated WT BL/6 mice and IRAK-2+/-
littermate controls (Fig. 5A). SEA-stimulated MLN CD4 T cells
from infected, SEA/CFA-immunized IRAK-2-/- mice also
produced significantly less IL-17 than BL/6 and IRAK-2+/-
controls, and barely above the levels of their unimmunized
counterparts (Fig. 5B). Interestingly, while IRAK-2 did not
significantly influence the levels of IFN-c or IL-5 (Fig. 5C,E), its
absence led to higher IL-4 production (Fig. 5D). These results
demonstrate that IRAK-2 plays a key role in the development of
severe immunopathology and IL-17 production in schistosomiasis.
IRAK-2 enhances IL-1-induced Th17 cell responses
IL-1b and IL-23 have been shown to play key roles in
pathogenic Th17 cell development from naive precursors
[26,27,38]. We have also demonstrated these cytokines to be
necessary for Th17 cell differentiation in high-pathology CBA
mice [28]. IRAK-2 plays a key role in MyD88 dependent TLR
Figure 6. IRAK-2 promotes CD4 T cell IL-17 production and Th17 lineage commitment and activation. (A) Naı ¨ve splenic CD4 T cells from
BL/6, Why1 and IRAK-2-/- mice were stimulated with 4 ng/ml of IL-1b, or 20 ng/ml of IL-23, or both, for 96 hours, and IL-17 production was measured
by ELISA. Naı ¨ve splenic CD4 T cells were stimulated with anti-CD3/CD28 plus IL-1b, at indicated concentrations, either (B) alone or (C) in the presence
of 20 ng/ml of IL-23 for 96 hours, and IL-17 production was measured by ELISA. Naı ¨ve splenic CD4 T cells were stimulated with anti-CD3/CD28 plus
0.4 ng/ml of IL-1b, and (D) IL-22, (E) IL-23R, (F) Rorct and (G) BATF expression were measured by quantitative real-time PCR analysis at the indicated
time points. Data were normalized to GAPDH. Error bars represent means of triplicate determinations +/- SD. (H) BL/6 and Why1 CD4 T cells were
stimulated with 4 ng/ml of IL-1b for the indicated times and cytoplasmic protein lysates were analyzed by Western blot for MAPK (P-Erk) and NF-kB
(P-p105) pathway activity. Unphosphorylated p38 kinase was used as a loading control. Densitometric analysis of band intensities was determined for
the phospho-p105 blot, in which each band was normalized to its -p38 counterpart and the relative intensities were calculated. Data are
representative of 3 (A-G) or 2 (H) independent experiments. P values were determined by one-way ANOVA and student’s t test using GraphPad Prism
software (*=p,0.05, **=p,0.001).
doi:10.1371/journal.ppat.1002272.g006
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receptor [39,40]. Our results suggest that the role of IRAK-2 in
Th17 cell development is T cell intrinsic (Figure 3B–F). To
address the molecular basis by which wild-derived IRAK-2 leads
to enhanced IL-17 production, we stimulated naı ¨ve CD4 T cells
with IL-1 and IL-23, alone or in combination, and found that IL-1
per se induced IL-17 production only in CD4 T cells from Why1,
but not from BL/6 or IRAK-2-/- mice (Fig. 6A); IL-23 alone was
ineffective. Since IL-23 is known to induce IL-17 production in
memory Th17 cells [41,42] these results suggest that neither Why1
nor BL/6 T cells had a pre-existing memory phenotype. Rather,
IL-23 synergized with IL-1 for a significantly greater IL-17
production by Why1 than either BL/6 or IRAK-2-/- cells (Fig.
6A). In CD4 T cells additionally stimulated non-specifically with
anti-CD3/CD28, IL-1 again elicited significantly more IL-17
production in Why1 than in BL/6 cells, whereas the lowest levels
of IL-17 were produced by T cells from IRAK-2-/- mice (Fig.
6B). IL-23 markedly enhanced IL-1-induced IL-17 production by
Why1 and BL/6 T cells, but significantly less so in IRAK-2-/- T
cells (Fig. 6C). These results demonstrate that IL-1-induced IL-17
production by T cells is highly dependent on IRAK-2; they also
indicate that IL-23 by itself is unable to stimulate IL-17
production, but significantly potentiates IL-1 in carrying out this
function.
As further evidence of the role of IRAK-2 in boosting Th17
development, we found a significantly higher expression of the Th-
17-cell associated cytokine IL-22 in IL-1-stimulated CD4 T cells
from Why1 than from BL/6 or IRAK-2-/- mice (Fig. 6D). IL-
23R expression, which is a marker of activated and memory Th17
cells [41,43], was also significantly higher in anti-CD3/CD28 plus
IL-1 stimulated CD4 T cells from Why1 than from BL/6 or
IRAK-2-/- mice (Fig 6E). Additionally, in Why1 T cells there was
significantly higher expression of the Th17 cell lineage-associated
transcription factors RORct( Fig. 6F) and AP-1 B-cell activating
transcription factor (BATF) (Fig. 6G) [17,44]. Time course
analysis revealed an earlier and short-lived induction of Rorcti n
comparison with BATF, but at all times both expression levels
were higher in Why1 than in BL/6 cells, and were profoundly
down-regulated in IRAK-2-/- cells. Interferon regulatory factor 4
(IRF4) and the aryl hydrocarbon receptor (AHR) also play
important roles in Th17 cell biology[45,46,47], however, there
were no significant differences in their expression among the
various cell populations (not shown). Likewise, no significant
differences were observed in the induction of the Th1 and Th2
cell-associated transcription factors T-bet and Gata-3 (not shown).
For effective induction of responsive genes following TLR/IL-
1R stimulation, IRAK family kinases are known to activate a series
of downstream signaling events, including NF-kB and certain
MAPK family members[48,49]. To assess the effect of IRAK-2 on
these molecular mediators, CD4 T cells were stimulated with IL-1
and the activation of two pathways downstream of the IRAK
signaling complex, NF-kB and MAP kinases, were compared.
Western blot analysis of phosphorylation levels revealed that in
Why1 T cells there was enhanced activation of the IkB kinase
(IKK) family member p105 in comparison with BL/6 controls,
suggesting increased activation of the NF-kB axis via IL-1 receptor
signaling. At the same time, changes in Erk phosphorylation were
insignificant, indicating that the MAPK pathway is less affected by
the pro-inflammatory IRAK-2 isoform (Fig. 6H). Taken together,
these results suggest that IL-1-induced Th17 cell polarization via
IRAK-2 is associated with increased expression of the transcrip-
tion factors RORct and BATF, likely through enhancement of
NF-kB activity.
Discussion
Murine schistosomiasis is a well-established experimental model
of a major human infectious disease. Humans as well as mice
develop marked differences in disease severity and it is clear that
immunopathology is profoundly affected by the host genome.
Thus, a greater understanding of its pathogenic mechanisms and
underlying genes has widespread implications. Our laboratory has
identified several genetic intervals that are associated with severe
disease in mice [29,50], of which some correspond to regions in
the human genome that contain the loci Schistosoma mansoni 1 (Sm1)
and Sm2 [51,52,53]. Despite these efforts, specific genes that
control severe disease have not been identified to date. One reason
for this is the genetic redundancy of classical inbred mouse strains,
which facilitates genetic analysis of ‘‘simple’’ monogenic and fully
penetrant traits. However, greater genetic diversity may be
required when investigating traits that are conferred by multiple
loci that impart a quantitative contribution to the phenotype.
Hence, the limited diversity of classically used strains can make it
particularly difficult to identify genes that underlie complex traits,
such as those involved in the host response to schistosome
infection.
Using the more genetically diverse wild-derived mice as a
model, we provide evidence of how genetic mapping of complex
traits can be dissected with prior knowledge of the loci or genes
identified in relatively simple screens. Previously, we positionally
cloned a mutation in the promoter of IRAK-2C that limits the
expression of the inhibitory isoform of IRAK-2 in MOLF mice.
The outcome of this differential expression is a higher ratio of
proinflammatory IRAK-2A relative to the inhibitory isoform
IRAK-2C, which in turn leads to an enhanced proinflammatory
response in MOLF macrophages[31,54]. Extending these findings
to a physiological setting in vivo, we now show that addition of the
MOLF Why1 interval, which contains Irak2, markedly increases
the levels of IL-17 and the severity of egg-induced hepatic
immunopathology in schistosome-infected BL/6 mice. Using a
reciprocal approach, we also observed that the deletion of Irak2
leads to a significant defect in IL-17 production and a marked
reduction of immunopathology, thus identifying Irak2 as the causal
gene for this in vivo phenotype. The effect of Irak2 on
immunopathology is striking since susceptibility to S. mansoni
infection is likely conferred by many genes, which have been
elusive in previous genetic screens measuring immunopathology as
a direct phenotypic read-out. IRAK-2 was not identified in our
previous genetic screens in vivo [29,50]. This is not surprising
because these analyses were done in classical inbred mice, which
have different levels of pathology but similar IRAK-2 alleles, thus
precluding the assessment of the wild-derived IRAK-2 allele in T
cell activation during infection. The observed effect of the Why1
locus and Irak2 on pathology thus sets an important precedent for
how results of a genetic screen in vitro can be used for identification
of genes influencing complex traits in vivo.
IRAK family kinases are central to TLR signaling and a critical
factor in innate immunity [55]. Recently, IRAK family kinases
have been studied in the adaptive immune response with some
discrepancy as to their precise role. IRAK-4 has first been
suggested to be an essential factor in TCR induced T cell
responses[56]. However, these results have not been confirmed as
it was later shown that IRAK-4 is dispensable for normal T cell
responses and TCR activity[57,58]. Here we provide evidence
that another IRAK family member, IRAK-2, critically affects T
cell biology by regulating the ability of IL-1 to promote Th17
function. Thus, stimulation of T cells with either IL-1 alone, or
together with anti-CD3/CD28, resulted in a dramatic increase in
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while IL-17 from IRAK-2-/- T cells was minimal. Stimulation of
Why1 CD4 T cells with IL-1 also led to increased activation of the
IkB kinase p105, which promotes the degradation of IkB and
allows NF-kB to translocate to the nucleus [59]. These
observations identify IRAK-2 as a key regulator of Th17 cell
biology by enhancing IL-1R signaling through NF-kB activation.
This effect of IRAK-2 was specific to Th17 and did not affect IFN-
c production, which is in agreement with recent observations
linking NF-kB specifically with IL-17, but not IFN-c [34]. Our
data also show that stimulation with IL-1 in the absence of TCR
engagement is sufficient to induce IL-17 production in Why1 T
cells, suggesting that their high expression of IRAK-2 is
responsible for the increased Th17 responses. However, naive
BL/6, Why1 or IRAK-2 -/- T cells did not express the IL-23R or
respond to stimulation with IL-23, two hallmarks of activated/
memory Th17 cells [18,20,41,42,60,61], suggesting that neither
one was in a state of activation prior to stimulation. Altogether,
these findings imply that the role of IRAK family members in T
cell responses is not limited to an effect on TCR signaling, but
rather that they can also act via the IL-1R-MyD88 complex to
direct Th17 cell responses.
Among several candidate transcription factors, RORct has been
demonstrated to play a central role in Th17 cell differentiation, as
its absence significantly impairs IL-17 production [45,62]. We now
show that Why1 CD4 T cells significantly up-regulate RORct
expression following stimulation with IL-1, suggesting that IL-1 per
se can activate Th17 cells through an IRAK-2 dependent pathway.
More recently, BATF was identified as a key transcription factor in
Th17 cell differentiation [44], as BATF-deficient mice displayed
impaired Th17 cell activity and were resistant to EAE despite
normal IL-6 signaling. BATF synergized with RORct to enhance
IL-17 production and sustained RORct expression in Th17 cells,
although the exact nature of their interaction remains to be
elucidated [63]. Here we show that BATF expression is
significantly enhanced in IL-17-producing Why1 CD4 T cells
compared with BL/6 T cells and that this function is IRAK-2
dependent. Interestingly, in our model RORct expression peaks
earlier than BATF (Fig 6F,G), suggesting that RORct may up-
regulate BATF during Th17 cell development. Our findings also
suggest that BATF functions downstream of the IL-1 receptor thus
explaining why BATF-/- mice have a defect in Th17 cell
differentiation [44,63]. IRF4 is another transcription factor
involved in Th17 cell differentiation via IL-21[45,64]. In our
system, stimulation with IL-1 resulted in increased IRF4
expression, but levels were not significantly different among BL/
6, Why1 or IRAK-2-/- T cells. Likewise, we found no significant
differences in the expression of AhR, which has a demonstrated
regulatory role in Th17 development and function [47,65] (data
not shown).
As demonstrated in this study, wild-derived IRAK-2 confers on
T cells a powerful, TCR-independent hypersensitivity to stimula-
tion with IL-1, which is further amplified in the presence of IL-23.
Mechanistically, this is due to a deletion in the IRAK-2C
promoter leading to unopposed activation of the main proin-
flammatory isoform of IRAK-2A. This contrasts with BL/6 mice,
in which the inhibitory isoform IRAK-2C is abundantly expressed
and up-regulated in response to inflammatory stimuli[31]. Tissue
inflammation induces large amounts of IL-1 and IL-23 and it has
been suggested that non-antigen specific Th17 cells responding to
these stimuli may aggravate tissue damage [26]. In schistosomiasis,
IL-1 and IL-23 are highly expressed in MLN and hepatic lesions of
high-pathology CBA, but not low-pathology BL/6 mice. Further-
more, dendritic cells derived from the bone marrows of normal
CBA mice produce abundant IL-1 and IL-23 in response to
stimulation with live schistosome eggs, whereas those from BL/6
mice do not, clearly linking these cytokines with exacerbated
disease [28,30]. Interestingly, IL-1 and IL-23 are also key
cytokines for human Th17 cell differentiation [66], and given
that humans contain only one proinflammatory isoform of IRAK-
2 similar to wild-derived mice [31], it is possible that IRAK-2 may
enhance the sensitivity of Th17 cells in a TCR-independent
manner and further aggravate immune-mediated tissue damage in
human inflammatory diseases.
In summary, using wild-derived mice as a model, we illustrate
the first example of a gene controlling severe pathology in murine
schistosomiasis, setting an example of how analysis of simple
monogenic traits in vitro can be applied to complex in vivo models of
infection or autoimmunity. We used this model to uncover a novel
role for IRAK-2 in CD4 T cell signaling via the IL-1 receptor and
show that IRAK-2 is a key regulator of IL-1-mediated Th17 cell
biology, which may have wide-ranging effects on other Th17 cell-
mediated inflammatory diseases.
Materials and Methods
Ethics statement
All the animal experiments were performed in accordance with
the Guide for the Care and Use of Laboratory Animals of the
National Institutes of Health and with the permission of the
American Association for the Assessment and Accreditation of
Laboratory Animal Care. The protocol was reviewed and
approved by the Tufts Medical Center Institutional Animal Care
and Use Committee and the Division of Laboratory Animal
Medicine (Permit Number: B2009-88).
Mice, infection and immunization
C57BL/6J, CBA/J and MOLF/Ei (MOLF) mice, 5-8wk old,
were purchased from the Jackson Laboratory. Why1 mice were
produced as previously described[31]. These congenic mice are
homozygous for the MOLF allele selected by marker D6Mit328
(chromosome 6 at 112.7 Mb) on a BL/6 background. IRAK-2-/-
mice were obtained from Dr. Shizuo Akira (Research Institute for
Microbial Diseases, Osaka, Japan). Mice were bred and
maintained at the Animal Facility at Tufts University School of
Medicine in accordance with the American Association for the
Assessment and Accreditation of Laboratory Animal Care
guidelines. Some mice were infected by i.p. injection with 85
cercariae of S. mansoni (Puerto Rico strain) obtained from infected
Biomphalaria galabrata snails provided by Dr. Fred Lewis (Biomed-
ical Research Institute) through National Institutes of Health/
National Institute of Allergy and Infectious Diseases Contract
N01-AI-55270. For some experiments, IRAK-2-/-, IRAK-2+/-
and BL/6 mice were immunized s.q. with 50 mg of SEA/CFA
before and after infection, as previously described[12]. SEA was
prepared as previously described[67].
Assessment of histopathology and egg burden
determinations
Formalin-fixed liver samples from 7 week-infected mice were
processed for histopathological analysis of 5-mm sections stained
with H & E. The extent of granulomatous inflammation around
schistosome eggs was measured by computer-assisted morphomet-
ric analysis using Image-Pro Plus software (Media Cybernetics) as
previously described[29]. At least 15 granulomas were counted per
liver. Granuloma size was expressed in square micrometers 6
SEM. The schistosome egg load was assessed by counting the
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2 fields of liver tissue in sections
stained with hematoxylin/eosin as previously described [68].
Cell preparations
MLNC suspensions were prepared from individual mice by
teasing the lymph nodes in supplemented RPMI 1640 medium
containing 10% FCS (Atlanta Biologicals) as previously de-
scribed[30]. CD4 T cells from MLN or spleens were purified by
negative selection using CD4 MACS columns (Miltenyi Biotec) in
accordance with manufacturer’s instructions. CD4 T cell purity
was .95% by FACS analysis. Liver granuloma cells were isolated
as previously described[12].
Cell cultures and cytokine determinations
Bulk MLNC or GC suspensions (5610
6 cells/ml), or purified
CD4 T cells (1610
6 cells/ml) plus normal irradiated syngeneic
splenic APC (4610
6 cells/ml), were incubated in the presence or
absence of 15 mg/ml SEA for 48hrs. IL-17, IFN-c, IL-6, TNFa,
IL-4, IL-5 and IL-10 protein concentrations in the cell culture
supernatants were measured by ELISA using standard cytokines,
Abs and protocols from R&D Systems.
Why1-BL/6 cell cocultures and in vivo CD4 T cell transfers
1610
6 purified MLN CD4 T cells from 7 week-infected BL/6
and Why1 mice were cultured ex vivo with 4610
6 irradiated naı ¨ve
splenic APCs from BL/6 or Why1 mice for 48 hours in the
presence or absence of 15 mg/ml of SEA. IL-17 levels in cell
supernatants were measured by ELISA as described. For the cell
transfer experiments, BL/6 recipient mice were sublethally
irradiated (500 rad) 3 days prior to infection and subsequently
injected i.v. with 8610
6 naı ¨ve splenic CD4 T cells from BL/6 or
Why1 donor mice, purified by negative selection as described
above. After 7 weeks of infection, IL-17 production by SEA-
stimulated bulk MLNC, and by purified MLN CD4 T cells plus
irradiated naı ¨ve splenic APC, was measured by ELISA as
described.
Quantitative Real-time RT-PCR
Total RNA was isolated from individual samples using TriZol
reagent (Invitrogen) as per manufacturers instructions. RNA (1–
5 mg) was subjected to DNASE I treatment (Roche) and reverse-
transcribed using the high capacity cDNA reverse synthesis kit
(Applied Biosystems). Real-time quantitative RT-PCR was
performed by SYBR green or Taqman analysis using an ABI
7300 instrument. GAPDH levels were used to normalize the data.
Taqman real-time probes for IL-17, IFN-c, IL-4, IL-12p40, IL-
12p35, IL-23p19, IL-22, IL-1b, IL-23R and batf were obtained
from Applied Biosystems. Primers for SYBR green analysis of rorct
were described previously[17]. Using the average mean cycle
threshold (Ct) value for GAPDH and the gene of interest for each
sample, the equation 1.8 e (Ct GAPDH - Ct gene of interest)610
4
was used to obtain normalized values [69].
Western blot analysis
1610
6 cells CD4 T cells were stimulated with IL-1b (4 ng/ml,
R&D Systems) for 0, 5, 10, 20 and 30 minutes followed by lysis on
ice in a cytoplasmic lysis buffer (50 mM Tris, pH 8, 150 mM
NaCl, 2 mM EDTA, 1% Triton X-100, 1 mM NaVanadate and
10 mM NaF) supplemented with Halt protease inhibitor cocktail
(Thermo Fisher Scientific) for 10 min. Lysates were then
centrifuged at 13,000 rpm at 4uC for 10 min. Cleared lysates
were resolved on a 4-12% gradient Bis-Tris SDS gel (NuPAGE;
Invitrogen) and transferred to a nitrocellulose membrane. Rabbit
polyclonal antibodies to phosphorylated ERK and p105 were
obtained from Cell Signaling Technology. After incubation with
specific Abs, chemiluminescence was detected using ECL substrate
(Thermo Fisher Scientific).
Lentiviral transduction
To down-regulate the expression of IRAK-2 in mouse T cells,
we used infection with lentiviral particles expressing IRAK-2-
targeting shRNA. Lentiviral particles were produced by trans-
fecting (Fugene, Roche) 293-T cells with a plasmid encoding
IRAK-2-specific shRNA in the pLKO.1 vector (Open Biosystems
clone ID TRCN000022502) together with two other plasmids,
pSPAX2 and pMD2.G (Addgene), encoding packaging compo-
nents of the lentivirus. Supernatants from 293-T cells were
harvested on days 2 and 3 after transfection and passed through a
0.22 mm filter.
Naı ¨ve CD4 T cells were purified from normal Why1 and BL/6
mouse spleens using the Easysep kit (StemCells). T cells were
resuspended to a density of 2610
6 cells/ml and plated on 6 well
plates that were previously seeded with resident i.p. macrophages
from normal BL/6 mice (1.5610
6 cells/well). Viral supernatant
and medium were added at a 1:1 ratio for 18 hours. Subsequently,
the T cells were washed and allowed to recover for 96 hrs in the
presence of macrophages to promote survival. Non-adherent T
cells were re-plated at a concentration of 1610
6 viable cells/ml for
stimulation with anti-CD3/CD28. Cells and supernatants were
collected after 48 and 96 hrs.
Stimulation of naı ¨ve CD4 T cells
Naı ¨ve CD4 T cells were incubated in either 96 well plates
(3.5610
5 cells/ml) for ELISA detection, or 48 well plates
(1610
6 cells/ml) for real-time analysis in triplicates, and stimulat-
ed with anti-CD3/CD28 coated beads (3610
5, Dynal) together
with rIL-1b, at indicated concentrations, and rIL-23 (20 ng/ml).
For ELISA, cell culture supernatants were collected after 4 days
and analyzed for IL-17 as described. For real-time PCR, cells were
collected at 0, 2, 24, 48 and 96 hrs in Trizol reagent and assayed
as described.
Statistical analyses
ANOVA and Student’s t tests were used to determine the
statistical significance of the differences between groups and were
calculated with GraphPad Prism.
Accession numbers
Il17a (Mouse Genome Informatics:107364), Ifng (MGI:107656),
Il6(MGI:96559), Tnf (MGI:104798), Il4 (MGI:96556), Il5 (MGI:
96557), Il10 (MGI:96537), Irak2 (MGI:2429603), Rorc (MGI:
104856), Batf (MGI:1859147), Irf4 (MGI:1096873), Ahr (MGI:
105043).
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